MSMR Pub Date : 2024-02-20

Afton D Seeley, John W Castellani

引用次数: 0

Demographics of the Space Force active component, U.S. Armed Forces, November 2023. 2023 年 11 月美国武装部队太空部队现役人员人口统计。

MSMR Pub Date : 2024-02-20

Shauna L Stahlman, Thomas G Wilkerson

引用次数: 0

Incidence and health care burden of uterine fibroids among female service members in the active component of the U.S. Armed Forces, 2011-2022. 2011-2022 年美国武装部队现役女军人中子宫肌瘤的发病率和医疗负担。

MSMR Pub Date : 2024-02-20

Chiping Nieh, Sithembile L Mabila

{"title":"Incidence and health care burden of uterine fibroids among female service members in the active component of the U.S. Armed Forces, 2011-2022.","authors":"Chiping Nieh, Sithembile L Mabila","doi":"","DOIUrl":"","url":null,"abstract":"Uterine fibroids are the most common benign tumors of the uterus among women of reproductive age, disproportionally affecting non-Hispanic Black women compared to other races and ethnicities. This report is an update of a 2011 MSMR report that examined uterine fibroids among female active component service members in the U.S. Armed Forces from 2001 to 2010. Incident uterine fibroids were identified for this report from inpatient and outpatient medical encounter data from 2011 to 2022. Health care burden was estimated utilizing uterine fibroid-related inpatient and outpatient diagnostic and procedure codes. Crude incidence rates and incidence rate ratios were calculated to compare rate differences between subpopulations. A total of 16,046 new uterine fibroid cases were identified, with an incidence rate of 63.5 cases per 10,000 person-years (95% confidence interval: 62.5-64.5). The highest incidence rates were observed among service women 40 years and older, non-Hispanic Black women, and those who served in the Army. Health care burden analysis showed that, even with increases in medical encounters and individuals affected, the numbers of hospital bed days declined over time. The decline in uterine fibroid-related hospital bed days could be attributed to early diagnoses and minimally-invasive treatments. Continued promotion of uterine fibroid awareness can potentially help further reduce uterine fibroid-related impacts on military readiness.","PeriodicalId":38856,"journal":{"name":"MSMR","volume":"31 2","pages":"9-15"},"PeriodicalIF":0.0,"publicationDate":"2024-02-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10959453/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140102558","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Weight loss medication prescription prevalence in the active component, 2018-2023. 2018-2023 年有效成分中减肥药物处方的流行率。

MSMR Pub Date : 2024-01-20

Nathan C Lorei, Shauna L Stahlman, Gi-Taik Oh, Natalie Y Wells

{"title":"Weight loss medication prescription prevalence in the active component, 2018-2023.","authors":"Nathan C Lorei, Shauna L Stahlman, Gi-Taik Oh, Natalie Y Wells","doi":"","DOIUrl":"","url":null,"abstract":"The U.S. military has witnessed rising obesity among active component service members. The Department of Defense authorized coverage of weight loss medications in 2018, but no study has evaluated prescription prevalence within the active component. This descriptive retrospective cohort study analyzed data from active component U.S. military service members from January 2018 through June 2023. The study used data from the Defense Medical Surveillance System to determine prescription period prevalence of weight loss medication. Data on demographics, body mass index, and history of diabetes were considered. The study revealed a 100-fold increase in the prescription period prevalence of weight loss agents in the active component from their initial authorization date. Demographics associated with higher prescription period prevalence were non-Hispanic Black race and ethnicity, female sex, and older age. Service members in the health care occupations and the Navy had higher prevalence compared to other service branches and occupations. The findings indicate a significant rise in the period prevalence of weight loss prescriptions over time. Further research is recommended to assess the effectiveness, safety, and use in austere military environments.","PeriodicalId":38856,"journal":{"name":"MSMR","volume":"31 1","pages":"9-13"},"PeriodicalIF":0.0,"publicationDate":"2024-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10914017/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139742256","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

The four most frequently diagnosed vector-borne diseases among service member and non-service member beneficiaries in the geographic combatant commands, 2010-2022. 2010-2022 年地域作战司令部军人和非军人受益人中最常诊断出的四种病媒传染疾病。

MSMR Pub Date : 2024-01-20

Ralph A Stidham, Ronald Cole, Sithembile L Mabila

{"title":"The four most frequently diagnosed vector-borne diseases among service member and non-service member beneficiaries in the geographic combatant commands, 2010-2022.","authors":"Ralph A Stidham, Ronald Cole, Sithembile L Mabila","doi":"","DOIUrl":"","url":null,"abstract":"Vector-borne diseases (VBDs) may pose an increased risk for U.S. service members during recurring military training exercises, operations, and response missions, in addition to residence in endemic regions within and outside the continental U.S. Prior MSMR reports address VBD surveillance, described by surveillance data for 23 reportable medical events (RMEs), among active duty and reserve component service members. This report covers a 13-year surveillance period, from January 2010 to December 2022, and provides linear trends of selected VBDs among Armed Forces service and non-service member beneficiaries diagnosed at installations within the Northern Command (NORTHCOM), Africa Command (AFRICOM), Central Command (CENTCOM), European Command (EUCOM), Indo-Pacific Command (INDOPACOM), or Southern Command (SOUTHCOM). Trends of only the 4 mostfrequently reported VBDs were evaluated, as Lyme disease, malaria, Rocky Mountain Spotted Fever (RMSF), and dengue fever comprised 90% (n=5,199) of all 23 VBDs (n=5,750) among Military Health System (MHS) beneficiaries documented as RMEs during the surveillance period.","PeriodicalId":38856,"journal":{"name":"MSMR","volume":"31 1","pages":"14-16"},"PeriodicalIF":0.0,"publicationDate":"2024-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10914018/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139742255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Ivermectin prescription fill rates among U.S. Military members during the coronavirus disease 2019 (COVID-19) pandemic. 2019 年冠状病毒病（COVID-19）大流行期间美国军人的伊维菌素处方配药率。

MSMR Pub Date : 2024-01-20

Shawn S Clausen, Jessica H Murray, Shauna L Stahlman

{"title":"Ivermectin prescription fill rates among U.S. Military members during the coronavirus disease 2019 (COVID-19) pandemic.","authors":"Shawn S Clausen, Jessica H Murray, Shauna L Stahlman","doi":"","DOIUrl":"","url":null,"abstract":"This report describes ivermectin prescription fill rates among U.S. active component service members (ACSM) over time during the early phases of the COVID-19 pandemic. Information about the unsubstantiated benefits of ivermectin for coronavirus 2019 (COVID-19) prevention and treatment was widely available online early in the COVID-19 pandemic. Ivermectin prescription fill rates increased among ACSM during periods of Alpha and Delta coronavirus variant predominance, but not during the predominance of the Omicron variant. At the peak of the fill rate curve, in August 2021, rates were higher among men compared to women, older compared to younger age groups, senior officers compared to junior officers, senior enlisted compared to junior enlisted service members, and those with a bachelor's or advanced degree compared to those without a bachelor's degree. Ivermectin prescriptions were more likely to have been filled at a retail pharmacy than at a military hospital or clinic. During the COVID-19 pandemic fill rates for ivermectin prescriptions among ACSM increased, including those without a qualifying diagnosis. Rates peaked in August 2021 but subsequently declined. The decrease in ivermectin fill rates was coincident with vigorous efforts to correct previous misinformation and implement pre-authorization requirements for prescriptions. Research on the impact of unproven online claims about clinical and public health interventions has potential to curtail future unnecessary and potentially harmful treatments.","PeriodicalId":38856,"journal":{"name":"MSMR","volume":"31 1","pages":"2-8"},"PeriodicalIF":0.0,"publicationDate":"2024-01-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10926958/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139742254","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

A content review of articles published in the Medical Surveillance Monthly Report, 2019-2023. 2019-2023年《医学监督月报》发表文章的内容回顾。

MSMR Pub Date : 2024-01-20

Kristen R Rossi, Robert N Pursley

引用次数: 0

Surveillance snapshot: chikungunya in service members of the U.S. Armed Forces, 2016-2022. 监测快照：2016-2022 年美国武装部队服役人员中的基孔肯雅病。

MSMR Pub Date : 2023-12-20

Shauna L Stahlman, Richard S Langton

引用次数: 0

Surveillance snapshot: mid-year populations by sex, age, and race and ethnicity of active component service members of the U.S. Armed Forces, 2018–2022 监测快照：2018-2022 年美国武装部队现役军人中按性别、年龄、种族和民族分列的年中人口数量

MSMR Pub Date : 2023-12-20

Alexis A McQuistan, Erika Dreyer, Sithembile L Mabila